Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: A randomized, double-blind, placebo-controlled trial

Inflammatory Bowel Diseases

Volumn 19, Issue 9, 2013, Pages 1889-1895

  Mañosa, Míriam ^a,b   Cabré, Eduard ^a,b   Bernal, Isabel ^a   Esteve, Maria ^b,c   Garcia Planella, Esther ^d   Ricart, Elena ^b,d   Peñalva, Mireia ^e   Cortes, Xavier ^f   Boix, Jaume ^a   Piñol, Marta ^a   Gassull, Miquel A ^a   Domènech, Eugeni ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL MÚTUA DE TERRASSA   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HOSPITAL DE SAGUNTO   (Spain)

Author keywords

Azathioprine; Crohn's disease; Metronidazole; Postsurgical recurrence

Indexed keywords

AZATHIOPRINE; METRONIDAZOLE; PLACEBO;

ACUTE PANCREATITIS; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSGEUSIA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTRANSAMINASEMIA; INTESTINE RESECTION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MOLLUSCUM CONTAGIOSUM; MULTICENTER STUDY; PARESTHESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK REDUCTION; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; AZATHIOPRINE; CROHN DISEASE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METRONIDAZOLE; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECURRENCE; YOUNG ADULT;

EID: 84884612439     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e31828ef13f     Document Type: Article

References (20)

1. Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a populationbased cohort. Gastroenterology. 2010;139:1147-1155.
2. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology. 2008;135:1106-1113.
3. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut. 1992;33:331-335.
4. Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665-672.
5. McLeod RS, Wolff BG, Steinhart AH, et al. Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease. Gastroenterology. 1997;113:1823-1827.
6. D'Haens GR, Vermeire S, Van AG, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology. 2008;135:1123-1129.
7. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262-267.
8. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology. 1995;108:1617-1621.
9. Rutgeerts P, Van AG, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856-861.
10. Learned-Coughlin S. Peripheral neuropathy induced by metronidazole. Ann Pharmacother. 1994;28:536.
11. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004;127:723-729.
12. Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology. 2004;127:730-740.
13. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990;99:956-963.
14. Domenech E, Manosa M, Bernal I, et al. Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis. 2008;14:508-513.
15. Nos P, Domenech E. Postoperative Crohn's disease recurrence: a practical approach. World J Gastroenterol. 2008;14:5540-5548.
16. Sandborn WJ, Feagan BG. The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain. Gastroenterology. 2004;127:990-993.
17. Doherty G, Bennett G, Patil S, et al. Interventions for prevention of postoperative recurrence of Crohn's disease. Cochrane Database Syst Rev. 2009;(4):CD006873.
18. Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004;2:731-743.
19. De CP, Kamm MA, Prideaux L, et al. Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm Bowel Dis. 2012;18: 758-777.
20. Marteau P, Lemann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut. 2006;55:842-847.